BEN
55
2
SE
49
2
NVDA
54
5
INTU
60
-3
BAX
38
-12
VFC
70
2
UNM
65
-7
EQIX
64
5
HPE
75
7
CMCSA
44
-2
AMG
77
3
PCG
74
2
GIS
58
-2
AES
47
-3
NTAP
59
4
ADM
47
2
EMN
56
-2
ABBV
59
13
ADP
54
-4
PFE
33
-8
BEN
55
2
SE
49
2
NVDA
54
5
INTU
60
-3
BAX
38
-12
VFC
70
2
UNM
65
-7
EQIX
64
5
HPE
75
7
CMCSA
44
-2
AMG
77
3
PCG
74
2
GIS
58
-2
AES
47
-3
NTAP
59
4
ADM
47
2
EMN
56
-2
ABBV
59
13
ADP
54
-4
PFE
33
-8
Financhill
Back

The New York Times Co. Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
86

NYT
The New York Times Co.

Last Price:
$70.79
Seasonality Move:
5.79%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
86
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $70.79. The Score for NYT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $70.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.19 Buy
Relative Strength Index (14 RSI): 81.3 Buy
Chaikin Money Flow: -68133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.45 - 67.91) Buy
Bollinger Bands (100): (55.74 - 63.94) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.65 Buy
20-day SMA: 66.2 Buy
50-day SMA: 61.77 Buy
200-day SMA: 56.22 Buy
8-day EMA: 68.7 Buy
20-day EMA: 66.52 Buy
50-day EMA: 63.24 Buy
200-day EMA: 57.7 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):